The London markets have recently faced challenges, with the FTSE 100 and FTSE 250 indices slipping due to weak trade data from China, highlighting ongoing global economic uncertainties. Despite these broader market fluctuations, investors often turn their attention to penny stocks as a potential avenue for growth. While the term ‘penny stock’ might seem outdated, it continues to signify opportunities in smaller or newer companies that possess solid financial foundations and the potential for notable returns.
Name
Share Price
Market Cap
Financial Health Rating
Foresight Group Holdings (LSE:FSG)
Β£4.57
Β£524.54M
β β β β β β
Warpaint London (AIM:W7L)
Β£1.85
Β£149.46M
β β β β β β
Ingenta (AIM:ING)
Β£1.07
Β£16.15M
β β β β β β
Integrated Diagnostics Holdings (LSE:IDHC)
$0.67
$389.49M
β β β β β β
Michelmersh Brick Holdings (AIM:MBH)
Β£0.84
Β£76.15M
β β β β β β
Impax Asset Management Group (AIM:IPX)
Β£1.608
Β£194.75M
β β β β β β
M.T.I Wireless Edge (AIM:MWE)
Β£0.545
Β£46.98M
β β β β β β
Begbies Traynor Group (AIM:BEG)
Β£1.18
Β£189.9M
β β β β β β
ME Group International (LSE:MEGP)
Β£1.398
Β£545.56M
β β β β β β
Billington Holdings (AIM:BILN)
Β£3.90
Β£50.91M
β β β β β β
Click here to see the full list of 288 stocks from our UK Penny Stocks screener.
We’re going to check out a few of the best picks from our screener tool.
Simply Wall St Financial Health Rating: β β β β β β
Overview: Impax Asset Management Group Plc is a publicly owned investment manager with a market cap of approximately Β£194.75 million.
Operations: The company’s revenue segment, Impax LN, generated Β£141.87 million.
Market Cap: Β£194.75M
Impax Asset Management Group Plc, with a market cap of Β£194.75 million, presents a mixed picture for investors interested in penny stocks. The company is debt-free and has not diluted shareholders recently, indicating financial stability. However, its recent earnings report showed a decline in net income to Β£20.29 million from Β£36.48 million the previous year, alongside reduced profit margins and dividends. Despite trading at good value compared to peers and having seasoned management, Impax’s negative earnings growth over the past year highlights challenges in maintaining profitability amidst industry pressures. Nonetheless, its short-term assets comfortably cover both short- and long-term liabilities.
AIM:IPX Debt to Equity History and Analysis as at Jan 2026
Simply Wall St Financial Health Rating: β β β β β β
Story Continues